Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk ? No

Tallantyre, Emma C. ORCID: https://orcid.org/0000-0002-3760-6634 2022. Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk ? No. Multiple Sclerosis Journal 28 (8) , pp. 1175-1177. 10.1177/13524585221091404

Preview

PDF - Accepted Post-Print Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (174kB) | Preview

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Publisher:	SAGE Publications
ISSN:	1352-4585
Date of First Compliant Deposit:	8 June 2022
Date of Acceptance:	14 March 2022
Last Modified:	19 Nov 2024 21:00
URI:	https://orca.cardiff.ac.uk/id/eprint/150297

Citation Data

Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item